Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer Academic Article uri icon

Overview

MeSH Major

  • Bone Marrow Diseases
  • Breast Neoplasms
  • Granulocyte Colony-Stimulating Factor
  • Paclitaxel

abstract

  • Taxol is highly active as initial chemotherapy for metastatic breast cancer. Administration of rhG-CSF reduced the incidence, depth, and duration of neutropenia, compared with published prior experience. Further studies of Taxol in breast cancer, including combinations with other active agents, are clearly warranted.

publication date

  • October 27, 1993

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 7691998

Additional Document Info

start page

  • 1943

end page

  • 51

volume

  • 11

number

  • 10